16699
Although ABT - 384 exposures were greatly increased in the presence of ketoconazole , coadministration of ABT - 384 with ketoconazole or other strong / moderate CYP3A inhibitors is not expected to contribute to any major clinical safety issues considering the favorable safety profile of ABT - 384 .
 Chemical: ABT - 384; Chemical: ketoconazole; Chemical: ABT - 384; Chemical: ketoconazole; Chemical: ABT - 384
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: ABT - 384; Chemical: ketoconazole; Chemical: ABT - 384; Chemical: ketoconazole; Chemical: ABT - 384